Latest Advances in Cardiovascular Risk in Primary Hyperparathyroidism

doi:10.12114/j.issn.1007-9572.2021.00.572

Abstract

Abstract: Primary hyperparathyroidism（PHPT） is an endocrine disease in which parathyroid hormone is excessive secreted，causing disorders of calcium and phosphorus metabolism，and then leading to the involvement of many systems in the whole body. Hypertension，diabetes，dyslipidemia，cardiovascular endothelial dysfunction，arrhythmia and left ventricular hypertrophy are major cardiovascular risk factors for PHPT，and cardiovascular metabolic characteristics of PHPT have been widely studied. We reviewed many recent studies about PHPT with cardiovascular involvement，described and summarized the major research results，aiming to improve clinical workers' understanding of knowledge in this field and to provide help for them in developing options that maximize the benefits.

Key words: Hyperparathyroidism, primary；Cardiovascular diseases；Parathyroid hormone；Hypertension；Review

摘要： 原发性甲状旁腺功能亢进症（PHPT）是一种由于甲状旁腺激素（PTH）分泌过多造成钙、磷代谢紊乱而导致全身多个系统受累的内分泌疾病。高血压、糖尿病、血脂异常、血管内皮功能障碍、心律失常和左心室肥厚是PHPT的主要心血管危险因素，目前，PHPT的心血管代谢特征已被广泛研究。本文纳入了国内外多篇描述PHPT患者中心血管受累的文献，总结并分析了其研究结果，旨在提高临床工作者对PHPT患者心血管受累的认识，为临床制定PHPT的获益最大化治疗提供参考。

关键词: 甲状旁腺功能亢进, 原发性；心血管疾病；甲状旁腺素；高血压；综述

HE Chunhua,WANG Jinfang,WANG Qingguo. Latest Advances in Cardiovascular Risk in Primary Hyperparathyroidism　[J]. Chinese General Practice, 2021, 24(33): 4287-4292. DOI: 10.12114/j.issn.1007-9572.2021.00.572.
何春华,王金芳,王清国. 原发性甲状旁腺功能亢进症患者的心血管风险研究进展[J]. 中国全科医学, 2021, 24(33): 4287-4292. DOI: 10.12114/j.issn.1007-9572.2021.00.572.

References

［1］ZHU C Y，STURGEON C，YEH M W.Diagnosis and management of primary hyperparathyroidism［J］．JAMA，2020，323（12）：1186-1187．DOI：10.1001/jama.2020.0538.
［2］NILSSON I L.Primary hyperparathyroidism：should surgery be performed on all patients? Current evidence and residual uncertainties［J］．J Intern Med，2019，285（2）：149-164．DOI：10.1111/joim.12840.
［3］PEPE J，CIPRIANI C，SONATO C，et al．Cardiovascular manifestations of primary hyperparathyroidism：a narrative review［J］．Eur J Endocrinol，2017，177（6）：R297-308．DOI：10.1530/EJE-17-0485.
［4］BOLLERSLEV J，SJ?STEDT E，REJNMARK L.Cardiovascular consequences of parathyroid disorders in adults［J］．Ann Endocrinol（Paris），2021，82（3/4）：151-157．DOI：10.1016/j.ando.2020.02.003.
［5］ZHU C Y，NGUYEN D T，YEH M W.Who benefits from treatment of primary hyperparathyroidism?［J］．Surg Clin North Am，2019，99（4）：667-679．DOI：10.1016/j.suc.2019.04.007.
［6］REID L J，MUTHUKRISHNAN B，PATEL D，et al．Predictors of nephrolithiasis，osteoporosis，and mortality in primary hyperparathyroidism［J］．J Clin Endocrinol Metab，2019，104（9）：3692-3700．DOI：10.1210/jc.2018-02483.
［7］ZHENG M H，LI F X Z，XU F，et al．The interplay between the renin-angiotensin-aldosterone system and parathyroid hormone［J］．Front Endocrinol（Lausanne），2020，11：539．DOI：10.3389/fendo.2020.00539.
［8］FUJII H.Association between parathyroid hormone and cardiovascular disease［J］．Ther Apher Dial，2018，22（3）：236-241．DOI：10.1111/1744-9987.12679.
［9］LEIFHEIT-NESTLER M，RICHTER B，BASARAN M，et al．Impact of altered mineral metabolism on pathological cardiac remodeling in elevated fibroblast growth factor 23［J］．Front Endocrinol：Lausanne，2018，9：333．DOI：10.3389/fendo.2018.00333.
［10］GOLTZMAN D.Physiology of parathyroid hormone［J］．Endocrinol Metab Clin N Am，2018，47（4）：743-758．DOI：10.1016/j.ecl.2018.07.003.
［11］LANDSTROM A P，DOBREV D，WEHRENS X H T.Calcium signaling and cardiac arrhythmias［J］．Circ Res，2017，120（12）：1969-1993．DOI：10.1161/circresaha.117.310083.
［12］GRUSON D.PTH and cardiovascular risk［J］．Ann Endocrinol（Paris），2021，82（3/4）：149-150．DOI：10.1016/j.ando.2020.02.005.
［13］RASHID G，BERNHEIM J，GREEN J，et al．Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor［J］．Eur J Clin Invest，2008，38（11）：798-803．DOI：10.1111/j.1365-2362.2008.02033.x.
［14］ZHANG H，GAO Y，WANG Y M，et al．The effects of parathyroid hormone-related peptide on cardiac angiogenesis，apoptosis，and function in mice with myocardial infarction［J］．J Cell Biochem，2019，120（9）：14745-14755．DOI：10.1002/jcb.28735.
［15］FERREIRA DE ALMEIDA L，DELLA COLETTA FRANCESCATO H，ANTUNES-RODRIGUES J，et al．Imbalance of pro- and anti-angiogenic factors due to maternal vitamin D deficiency causes renal microvasculature alterations affecting the adult kidney function［J］．Nutrients，2019，11（8）：1929．DOI：10.3390/nu11081929.
［16］FISHER S B，PERRIER N D.Primary hyperparathyroidism and hypertension［J］．Gland Surg，2020，9（1）：142-149．DOI：10.21037/gs.2019.10.21.
［17］MCMULLAN C J，BORGI L，CURHAN G C，et al．The effect of vitamin D on renin-angiotensin system activation and blood pressure：a randomized control trial［J］．J Hypertens，2017，35（4）：822-829．DOI：10.1097/HJH.0000000000001220.
［18］GRAFF-BAKER A N，BRIDGES L T，CHEN Q L，et al．Parathyroidectomy for patients with primary hyperparathyroidism and associations with hypertension［J］．JAMA Surg，2020，155（1）：32-39．DOI：10.1001/jamasurg.2019.3950.
［19］NELSON J A，ALSAYED M，MILAS M.The role of parathyroidectomy in treating hypertension and other cardiac manifestations of primary hyperparathyroidism［J］．Gland Surg，2020，9（1）：136-141．DOI：10.21037/gs.2019.12.12.
［20］RYDBERG E，BIRGANDER M，BONDESON A G，et al．Effect of successful parathyroidectomy on 24-hour ambulatory blood pressure in patients with primary hyperparathyroidism［J］．Int J Cardiol，2010，142（1）：15-21．DOI：10.1016/j.ijcard.2008.12.027.
［21］TUNA M M，?AL1SKAN M，üNAL M，et al．Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism［J］．J Bone Miner Metab，2016，34（3）：331-335．DOI：10.1007/s00774-015-0673-3.
［22］MANIERO C，FASSINA A，SECCIA T M，et al．Mild hyperparathyroidism：a novel surgically correctable feature of primary aldosteronism［J］．J Hypertens，2012，30（2）：390-395．DOI：10.1097/HJH.0b013e32834f0451.
［23］TOMASCHITZ A，VERHEYEN N，MEINITZER A，et al．Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism：results from the EPATH randomized，placebo-controlled trial［J］．J Hypertens，2016，34（7）：1347-1356．DOI：10.1097/HJH.0000000000000927.
［24］CHANG T I，ABDALLA S，LONDON G M，et al．The effects of cinacalcet on blood pressure，mortality and cardiovascular endpoints in the EVOLVE trial［J］．J Hum Hypertens，2016，30（3）：204-209．DOI：10.1038/jhh.2015.56.
［25］KARRAS S N，KOUFAKIS T，TSEKMEKIDOU X，et al．Increased parathyroid hormone is associated with higher fasting glucose in individuals with normocalcemic primary hyperparathyroidism and prediabetes：a pilot study［J］．Diabetes Res Clin Pract，2020，160：107985．DOI：10.1016/j.diabres.2019.107985.
［26］KARRAS S N，ANAGNOSTIS P，ANTONOPOULOU V，et al．The combined effect of vitamin D and parathyroid hormone concentrations on glucose homeostasis in older patients with prediabetes：a cross-sectional study［J］．Diab Vasc Dis Res，2018，15（2）：150-153．DOI：10.1177/1479164117738443.
［27］PROCOPIO M，BARALE M，BERTAINA S，et al．Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms［J］．Endocrine，2014，47（2）：581-589．DOI：10.1007/s12020-013-0091-z.
［28］SHIMODAIRA M，NIWA T，NAKAJIMA K，et al．The relationship between serum calcium level and early-phase insulin secretion in normoglycemic and pre-diabetic individuals［J］．Exp Clin Endocrinol Diabetes，2015，123（3）：165-169．DOI：10.1055/s-0034-1394382.
［29］CARDENAS M G，VIGIL K J，TALPOS G B，et al．Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism［J］．Endocr Pract，2008，14（1）：69-75．DOI：10.4158/EP.14.1.69.
［30］TEMIZKAN S，KOCAK O，AYDIN K，et al．Normocalcemic hyperparathyroidism and insulin resistance［J］．Endocr Pract，2015，21（1）：23-29．DOI：10.4158/EP14195.OR.
［31］HAGSTR?M E，LUNDGREN E，RASTAD J，et al．Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening［J］．Eur J Endocrinol，2006，155（1）：33-39．DOI：10.1530/eje.1.02173.
［32］YENER OZTURK F，EROL S，CANAT M M，et al．Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients［J］．Endocr J，2016，63（2）：111-118．DOI：10.1507/endocrj.EJ15-0392.
［33］AL-HRAISHAWI H，DELLATORE P J，CAI X J，et al．Intact parathyroid hormone levels and primary hyperparathyroidism［J］．Endocr Res，2017，42（3）：241-245．DOI：10.1080/07435800.2017.1292528.
［34］BEYSEL S，CALISKAN M，KIZILGUL M，et al．Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism［J］．BMC Cardiovasc Disord，2019，19（1）：106．DOI：10.1186/s12872-019-1093-4.
［35］EJLSMARK-SVENSSON H，ROLIGHED L，REJNMARK L.Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism：a randomized clinical trial［J］．J Clin Endocrinol Metab，2019，104（8）：3223-3232．DOI：10.1210/jc.2018-02456.
［36］COLAK S，AYDOGAN B I，GOKCAY CANPOLAT A，et al．Is primary hyperparathyroidism a cause of endothelial dysfunction?［J］．Clin Endocrinol：Oxf，2017，87（5）：459-465．DOI：10.1111/cen.13418.
［37］CARRELLI A L，WALKER M D，DI TULLIO M R，et al．Endothelial function in mild primary hyperparathyroidism［J］．Clin Endocrinol（Oxf），2013，78（2）：204-209．DOI：10.1111/j.1365-2265.2012.04485.x.
［38］ROSA J，RASKA I Jr，WICHTERLE D，et al．Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy［J］．Hypertens Res，2011，34（3）：296-300．DOI：10.1038/hr.2010.232.
［39］BARLETTA G，DE FEO M L，DEL BENE R，et al．Cardiovascular effects of parathyroid hormone：a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism［J］．J Clin Endocrinol Metab，2000，85（5）：1815-1821．DOI：10.1210/jcem.85.5.6514.
［40］FARAHNAK P，RING M，CAIDAHL K，et al．Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy［J］．Eur J Endocrinol，2010，163（3）：461-467．DOI：10.1530/eje-10-0201.
［41］PERSSON A，BOLLERSLEV J，ROSEN T，et al．Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism［J］．Clin Endocrinol（Oxf），2011，74（2）：174-180．DOI：10.1111/j.1365-2265.2010.03909.x.
［42］OZDEMIR D，KALKAN G Y，BAYRAM N A，et al．Evaluation of left ventricle functions by tissue Doppler，strain，and strain rate echocardiography in patients with primary hyperparathyroidism［J］．Endocrine，2014，47（2）：609-617．DOI：10.1007/s12020-014-0245-7.
［43］MCMAHON D J，CARRELLI A，PALMERI N，et al．Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism：a meta-analysis［J］．J Clin Endocrinol Metab，2015，100（12）：4399-4407．DOI：10.1210/jc.2015-3202.
［44］VERHEYEN N，FAHRLEITNER-PAMMER A，BELYAVSKIY E，et al．Relationship between bone turnover and left ventricular function in primary hyperparathyroidism：the EPATH trial［J］．PLoS One，2017，12（4）：e0173799．DOI：10.1371/journal.pone.0173799.
［45］AKTAS YILMAZ B，AKYEL A，KAN E，et al．Cardiac structure and functions in patients with asymptomatic primary hyperparathyroidism［J］．J Endocrinol Invest，2013，36（10）：848-852．DOI：10.3275/8961.
［46］BEST C A E，KRISHNAN R，MALVANKAR-MEHTA M S，et al．Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism：a systematic review and meta-analysis［J］．Medicine：Baltimore，2017，96（43）：e7255．DOI：10.1097/md.0000000000007255.
［47］BUYUKSIMSEK M，GULUMSEK E，DEMIRTAS D，et al．Carotid-femoral pulse wave velocity is significantly increased in newly diagnosed hypertensive patients with primary hyperparathyroidism and significantly related with serum calcium level［J］．J Ultrasound，2020：1-8．DOI：10.1007/s40477-020-00512-4.
［48］DURAL C，OKOH A K，SEICEAN A，et al．A pilot study investigating the effect of parathyroidectomy on arterial stiffness and coronary artery calcification in patients with primary hyperparathyroidism［J］．Surgery，2016，159（1）：218-224．DOI：10.1016/j.surg.2015.07.037.
［49］OSTO E，FALLO F，PELIZZO M R，et al．Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy［J］．Circulation，2012，126（9）：1031-1039．DOI：10.1161/CIRCULATIONAHA.111.081307.
［50］KEPEZ A，HARMANCI A，HAZIROLAN T，et al．Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients［J］．Int J Cardiovasc Imaging，2009，25（2）：187-193．DOI：10.1007/s10554-008-9369-2.
［51］MESQUITA P N，DORNELAS LE?O LEITE A P，CHAGAS CRISóSTOMO S D，et al．Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism［J］．Vasc Health Risk Manag，2017，13：225-229．DOI：10.2147/vhrm.s128084.
［52］PALMERI N O，WALKER M D.Parathyroid hormone and cardiac electrophysiology：a review［J］．Cardiol Rev，2019，27（4）：182-188．DOI：10.1097/CRD.0000000000000250.
［53］PEPE J，CIPRIANI C，CURIONE M，et al．Reduction of arrhythmias in primary hyperparathyroidism，by parathyroidectomy，evaluated with 24-h ECG monitoring［J］．Eur J Endocrinol，2018，179（2）：117-124．DOI：10.1530/eje-17-0948.
［54］LIU F，XIN Z C，XIA Y L，et al．Bradycardia secondary to primary hyperparathyroidism［J］．J Int Med Res，2019，47（5）：2309-2311．DOI：10.1177/0300060519841156.
［55］ROSENQVIST M，NORDENSTR?M J，ANDERSSON M，et al．Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism［J］．Clin Endocrinol（Oxf），1992，37（1）：29-33．DOI：10.1111/j.1365-2265.1992.tb02279.x.
［56］BIRGANDER M，JUUL-M?LLER S，BONDESON A G，et al．Adrenergic and cardiac dysfunction in primary hyperparathyroidism［J］．Clin Endocrinol（Oxf），2012，76（2）：189-195．DOI：10.1111/j.1365-2265.2011.04169.x.
［57］LUNDGREN E，LIND L，PALMéR M，et al．Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years［J］．Surgery，2001，130（6）：978-985．DOI：10.1067/msy.2001.118377.
［58］WERMERS R A，KHOSLA S，ATKINSON E J，et al．Survival after the diagnosis of hyperparathyroidism：a population-based study［J］．Am J Med，1998，104（2）：115-122．DOI：10.1016/s0002-9343（97）00270-2.
［59］YU N，DONNAN P T，LEESE G P.A record linkage study of outcomes in patients with mild primary hyperparathyroidism：the Parathyroid Epidemiology and Audit Research Study （PEARS）［J］．Clin Endocrinol：Oxf，2011，75（2）：169-176．DOI：10.1111/j.1365-2265.2010.03958.x.
［60］CLIFTON-BLIGH P B，NERY M L，SUPRAMANIAM R，et al．Mortality associated with primary hyperparathyroidism［J］．Bone，2015，74：121-124．DOI：10.1016/j.bone.2014.12.067.

[1]	HUANG Zeyu, SU Lei, SANG Jianfeng, ZHAO Ru, HAN Chen, WANG Qian, GU Tianwei, BI Yan, ZHU Dalong, SHEN Shanmei. Clinical Characteristics and Risk Factors of Normocalcemic Primary Hyperparathyroidism [J]. Chinese General Practice, 2023, 26(11): 1369-1374.
[2]	WANG Yuxia，YU Lu，ZENG Qingcui，LIU Xiaofeng，LONG Huaicong. Hypocalcemic Tetany Caused by Hungry Bone Syndrome：a Case Report and Literature Review　 [J]. Chinese General Practice, 2019, 22(23): 2889-2892.
[3]	WANG Yan，ZHANG Jinsong，MIAO Gang，LI Miao，ZHOU Yan，ZHANG Lina. Clinical Features of Primary Hyperparathyroidism　 [J]. Chinese General Practice, 2018, 21(35): 4392-4396.